These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34653311)

  • 1. The AMPA receptor antagonist perampanel suppresses epileptic activity in human focal cortical dysplasia.
    Brito da Silva A; Pennifold J; Henley B; Chatterjee K; Bateman D; Whittaker RW; Joshi A; Kumar H; Nicholson C; Baker MR; Greenhill SD; Walsh R; Seri S; Jones RSG; Woodhall GL; Cunningham MO
    Epilepsia Open; 2022 Sep; 7(3):488-495. PubMed ID: 34653311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
    Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
    J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
    Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E
    Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perampanel: Does it have broad-spectrum potential?
    Potschka H; Trinka E
    Epilepsia; 2019 Mar; 60 Suppl 1():22-36. PubMed ID: 29953584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.
    Di Bonaventura C; Labate A; Maschio M; Meletti S; Russo E
    Expert Opin Pharmacother; 2017 Nov; 18(16):1751-1764. PubMed ID: 29023170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction: Perampanel--new mode of action and new option for patients with epilepsy.
    Steinhoff BJ
    Epilepsia; 2014 Jan; 55 Suppl 1():1-2. PubMed ID: 24400689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal seizures versus epileptic spasms in children with focal cortical dysplasia and epilepsy onset in the first year.
    Serino D; Freri E; Ragona F; D'Incerti L; Bernardi B; Di Ciommo V; Granata T; Vigevano F; Fusco L
    Epilepsy Res; 2015 Jan; 109():203-9. PubMed ID: 25524860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electro-clinical analysis of epilepsy patients with generalized seizures on adjunctive perampanel treatment.
    Montoya Gutiérrez FJ; Díaz Román M; Cerveró Albert D
    Epilepsy Res; 2020 Sep; 165():106378. PubMed ID: 32622260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist.
    Rogawski MA; Hanada T
    Acta Neurol Scand Suppl; 2013; (197):19-24. PubMed ID: 23480152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of perampanel in epilepsy.
    Satlin A; Kramer LD; Laurenza A
    Acta Neurol Scand Suppl; 2013; (197):3-8. PubMed ID: 23480150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel.
    Zaccara G; Giovannelli F; Cincotta M; Iudice A
    Expert Rev Neurother; 2013 Jun; 13(6):647-55. PubMed ID: 23739002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AMPA receptor antagonist perampanel is a new hope in the treatment for epilepsy.
    El Desoky ES
    Fundam Clin Pharmacol; 2014 Oct; 28(5):473-80. PubMed ID: 24750493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abolishing spontaneous epileptiform activity in human brain tissue through AMPA receptor inhibition.
    Wright SK; Wilson MA; Walsh R; Lo WB; Mundil N; Agrawal S; Philip S; Seri S; Greenhill SD; Woodhall GL
    Ann Clin Transl Neurol; 2020 Jun; 7(6):883-890. PubMed ID: 32426918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical outcome and predictive factors of epilepsy surgery in pediatric isolated focal cortical dysplasia.
    Choi SA; Kim SY; Kim H; Kim WJ; Kim H; Hwang H; Choi JE; Lim BC; Chae JH; Chong S; Lee JY; Phi JH; Kim SK; Wang KC; Kim KJ
    Epilepsy Res; 2018 Jan; 139():54-59. PubMed ID: 29197666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
    Lange F; Weßlau K; Porath K; Hörnschemeyer MF; Bergner C; Krause BJ; Mullins CS; Linnebacher M; Köhling R; Kirschstein T
    PLoS One; 2019; 14(2):e0211644. PubMed ID: 30716120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of perampanel in young children with drug-resistant epilepsy.
    Chang FM; Fan PC; Weng WC; Chang CH; Lee WT
    Seizure; 2020 Feb; 75():82-86. PubMed ID: 31901668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery and development of perampanel for the treatment of epilepsy.
    Hanada T
    Expert Opin Drug Discov; 2014 Apr; 9(4):449-58. PubMed ID: 24559052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPA receptors as a molecular target in epilepsy therapy.
    Rogawski MA
    Acta Neurol Scand Suppl; 2013; (197):9-18. PubMed ID: 23480151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.